Advertisement
Screener

CRONOS GROUP INC. (CRON) Deferred Foreign Income Tax Expense (Benefit)

2.2 / 5 stars · 30/68 Roast Me

CRONOS GROUP INC. Deferred Foreign Income Tax Expense (Benefit)

CRONOS GROUP INC. (CRON) reported Deferred Foreign Income Tax Expense (Benefit) of -$1.73 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-26

  • CRONOS GROUP INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$1.73M.
  • CRONOS GROUP INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$83.00K, a 218.57% decline from fiscal 2023.
  • CRONOS GROUP INC. deferred foreign income tax expense (benefit) for fiscal 2023 was $70.00K.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 month
2025-12-31-$1.73M
10-K · filed 2026-02-26
2024-12-31-$83.00K
10-K · filed 2026-02-26
2023-12-31$70.00K
10-K · filed 2026-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87